News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
792 Results
Type
Article (42)
Company Profile (1)
Press Release (749)
Section
Business (225)
Deals (53)
Drug Development (150)
FDA (14)
Job Trends (17)
News (437)
Policy (48)
Tag
Academia (2)
Alliances (53)
Approvals (19)
Artificial intelligence (1)
Best Places to Work (9)
Biotechnology (1)
Breast cancer (4)
Cancer (4)
Cell therapy (1)
Clinical research (142)
Collaboration (4)
Compensation (2)
COVID-19 (4)
C-suite (2)
Data (9)
Diagnostics (5)
Duchenne muscular dystrophy (21)
Earnings (107)
Events (126)
Executive appointments (1)
FDA (22)
Funding (3)
GLP-1 (2)
Government (4)
Guidances (1)
Healthcare (6)
Infectious disease (4)
IPO (44)
Job creations (6)
Layoffs (4)
Legal (5)
Manufacturing (3)
Medical device (17)
Medtech (17)
Mergers & acquisitions (9)
Neurodegenerative disease (1)
Neuroscience (1)
NextGen: Class of 2026 (12)
Non-profit (2)
Pain (1)
People (70)
Phase 1 (25)
Phase 2 (63)
Phase 3 (69)
Pipeline (14)
Postmarket research (3)
Preclinical (10)
Rare diseases (4)
Real estate (1)
Regulatory (52)
Research institute (2)
Series A (1)
Series B (1)
Startups (5)
Vaccines (3)
Date
Last 30 days (1)
Last 365 days (52)
2026 (4)
2025 (55)
2024 (60)
2023 (65)
2022 (66)
2021 (63)
2020 (70)
2019 (50)
2018 (30)
2017 (44)
2016 (40)
2015 (31)
2014 (34)
2013 (43)
2012 (37)
2011 (32)
2010 (27)
Location
Arkansas (1)
Asia (71)
Australia (5)
California (4)
Canada (1)
China (2)
Europe (132)
India (1)
Japan (2)
Massachusetts (31)
Nevada (1)
New York (5)
Northern California (2)
Pennsylvania (4)
South America (2)
Southern California (2)
United States (45)
792 Results for "spero therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
December 22, 2025
·
3 min read
Press Releases
Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek
October 15, 2025
·
5 min read
Press Releases
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
November 14, 2025
·
8 min read
Press Releases
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 28, 2025
December 1, 2025
·
1 min read
Press Releases
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
November 4, 2025
·
1 min read
Press Releases
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update
August 12, 2025
·
10 min read
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025
August 6, 2025
·
1 min read
Press Releases
Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
April 28, 2025
·
4 min read
Press Releases
Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update
May 14, 2025
·
8 min read
1 of 80
Next
